EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Targeting STAT3 to Modulate the Effectiveness of Cardioprotective Conditioning Strategies Against Myocardial Ischemia–Reperfusion Injury in Subjects With Diabetic Cardiomyopathy

Chunyan Wang iD, Wangli Tian iD, Saman Saedi, Hengzhen Cui, Danyong Liu, Qinjun Chu, Dongwei Yang, Zhengyuan Xia iD

Journal of Cellular and Molecular Medicine · 2026-10 · 30 (20)

DOI: 10.1111/jcmm.71418 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Cellular and Molecular Medicine, online erschienen am 23.10.2026. Verfasst von Chunyan Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Trauma and Metabolism, Zhengzhou Central Hospital Affiliated With Zhengzhou University, Zhengzhou, China. Hauptthemen laut MEDLINE: STAT3 Transcription Factor, Myocardial Reperfusion Injury, Diabetic Cardiomyopathies, Ischemic Preconditioning, Myocardial. Die Arbeit nennt 98 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science, Technology and Innovation Commission of Shenzhen Municipality, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Myocardial ischemia–reperfusion injury (MIRI) is a major cause of cardiovascular morbidity and mortality. Reperfusion, although essential for myocardial restoration, can paradoxically exacerbate injury through oxidative stress, calcium overload, mitochondrial permeability transition pore opening and inflammatory infiltration. The vulnerability to MIRI is substantially amplified in subjects with diabetes mellitus, where chronic hyperglycemia, insulin resistance, and the resulting oxidative stress and low‐grade inflammation impair endogenous cardioprotective mechanisms and worsen postinfarction outcomes. Ischemic conditioning strategies, including preconditioning and postconditioning, serve as powerful innate methods to mitigate MIRI by exposing the myocardium to brief, sublethal ischemic episodes that activate crucial prosurvival signalling pathways. Among these pathways, the survivor activating factor enhancement pathway, which is mediated predominantly by signal transducer and activator of transcription 3 (STAT3), and the reperfusion injury salvage kinase pathway, which involves AKT and ERK, are particularly important. However, in many models of diabetes, diabetes‐induced STAT3 dysfunction may disrupt these protective pathways, often making conditioning stimuli less effective. The precise mechanisms underlying this impairment remain incompletely understood. Additionally, paradoxical changes in STAT3 expression have been reported, and key posttranslational modifications of STAT3 have not yet been investigated in the context of diabetic MIRI. This review provides a critical appraisal of the role, regulatory mechanisms and therapeutic potential of STAT3 in ischemic conditioning in patients with diabetes and discusses strategies aimed at restoring cardioprotection in this high‐risk population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

STAT3 Transcription FactorMyocardial Reperfusion InjuryDiabetic CardiomyopathiesIschemic Preconditioning, MyocardialHumansAnimalsSignal TransductionIschemic PostconditioningMyocardiumOxidative Stress

Stichwörter der Autor:innen

STAT3cardioprotectiondiabetes mellitusdiabetic cardiomyopathyischemic conditioningmyocardial ischemia–reperfusion injury

Substanzen

STAT3 Transcription Factor

Autor:innen und Institutionen

  • Institute of Trauma and Metabolism, Zhengzhou Central Hospital Affiliated With Zhengzhou University, Zhengzhou, China.
  • Department of Anesthesiology, Shenzhen Maternity and Child Healthcare Hospital, Shenzhen, Guangdong, China.
  • Department of Anesthesiology and Perioperative Medicine, Zhengzhou Central Hospital Affiliated With Zhengzhou University, Zhengzhou, China.
  • Cell Research and Transformation Center, Zhengzhou Central Hospital Affiliated With Zhengzhou University, Zhengzhou, China.
  • Department of Cardiology, Zhengzhou Central Hospital Affiliated With Zhengzhou University, Zhengzhou, China.
  • State Key Laboratory of Pharmaceutical Biotechnology, Department of Medicine, The University of Hong Kong, Hong Kong, China.

ORCID-Profile: Chunyan Wang, Wangli Tian, Zhengyuan Xia

Förderung

  • Science, Technology and Innovation Commission of Shenzhen Municipality
  • National Natural Science Foundation of China

Zitieren

APA

Wang, C., Tian, W., Saedi, S., Cui, H., Liu, D., Chu, Q., Yang, D., & Xia, Z. (2026). Targeting STAT3 to Modulate the Effectiveness of Cardioprotective Conditioning Strategies Against Myocardial Ischemia–Reperfusion Injury in Subjects With Diabetic Cardiomyopathy. Journal of Cellular and Molecular Medicine, 30(20). https://doi.org/10.1111/jcmm.71418

Vancouver

Wang C, Tian W, Saedi S, Cui H, Liu D, Chu Q, et al. Targeting STAT3 to Modulate the Effectiveness of Cardioprotective Conditioning Strategies Against Myocardial Ischemia–Reperfusion Injury in Subjects With Diabetic Cardiomyopathy. Journal of Cellular and Molecular Medicine. 2026;30(20). doi:10.1111/jcmm.71418

BibTeX
@article{Wang2026,
  author = {Wang, Chunyan and Tian, Wangli and Saedi, Saman and Cui, Hengzhen and Liu, Danyong and Chu, Qinjun and Yang, Dongwei and Xia, Zhengyuan},
  title = {Targeting STAT3 to Modulate the Effectiveness of Cardioprotective Conditioning Strategies Against Myocardial Ischemia–Reperfusion Injury in Subjects With Diabetic Cardiomyopathy},
  journal = {Journal of Cellular and Molecular Medicine},
  year = {2026},
  volume = {30},
  number = {20},
  doi = {10.1111/jcmm.71418}
}
Kostenlos starten →